Craniopharyngioma: Clinical Trials

74 trials for Craniopharyngioma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

37 completed, 10 recruiting, 9 active not recruiting, 7 unknown. 22 Phase 2, 17 Phase 1, 9 Not applicable, 6 Phase 3, 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 222Completed 10, Active not recruiting 6, Recruiting 5, Terminated 1
Phase 117Completed 13, Recruiting 2, Terminated 1, Unknown 1
Not applicable9Completed 3, Withdrawn 3, Recruiting 2, Not yet recruiting 1
Phase 36Completed 4, Not yet recruiting 1, Unknown 1
Early Phase 12Active not recruiting 1, Unknown 1
Phase 42Enrolling by invitation 1, Unknown 1

Follow Craniopharyngioma: new trials by email Literature Review of Craniopharyngioma trials Research Report on Craniopharyngioma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Comparative Study Evaluating the Impact of Intensive Dietary Care on Weight Change and Biological Parameters in Patients Who Underwent Surgery for Craniopharyngioma During the First Postoperative Year
Intensive dietary care - Craniopharyngioma
Not applicableNot yet recruitingAssistance Publique Hopitaux De Marseille752027-01-012026-09-22
SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years
Semaglutide (Wegovy) weekly injection, Placebo weekly Injection - Craniopharyngioma, Child
Phase 3Not yet recruitingUniversity Hospital, Angers502026-11-012026-09-29
China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm
Tumor resection followed by aneurysm treatment, Aneurysm treatment followed by tumor resection, Observation - Unruptured Intracranial Aneurysms, Pituitary Neuroendocrine Tumor
Active not recruitingCheng sen6082026-10-202026-10-21
AI-Assisted MRI Molecular Subtyping in Pediatric Brain Tumors
Pediatric Brain Tumors, Glioma
Not yet recruitingHuashan Hospital14002026-07-152026-07-23
Randomized Controlled Clinical Study on the Prophylactic Intraoperative Use of Desmopressin in Complex Sellar Region Tumors
Desmopressin (DDAVP), Control - Craniopharyngiomas, Pituitary Macroadenoma
Phase 4Enrolling by invitationZhaoyun Zhang1522026-06-022026-07-17
Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery
Anti-fog suction device-a 4 Fr multi-channel silicone catheter - Pituitary Adenoma, Craniopharyngioma
Not applicableRecruitingWest China Hospital202026-03-012026-06-30
Food Preferences and Craniopharyngiomas
Craniopharyngioma
Not yet recruitingAssistance Publique - Hôpitaux de Paris3462026-02-012026-02-23
ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients
68Ga-MY6349 PET/CT - Craniopharyngioma
Not applicableRecruitingDeling Li202025-07-042025-09-17
Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma
Anlotinib - Craniopharyngiomas
Phase 1 / Phase 2RecruitingNanfang Hospital, Southern Medical University572025-04-252025-11-18
Craniopharyngioma and Pregnancies
Questionnaire - Craniopharyngioma
RecruitingAssistance Publique - Hôpitaux de Paris1002025-03-242025-04-02
The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction
Endoscopic endonasal skull base surgery - Meningioma, Pituitary Disease
RecruitingUniversitaire Ziekenhuizen KU Leuven1542025-03-182025-04-23
Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity
Phentermine / Topiramate Extended Release Oral Capsule [Qsymia], Placebo - Hypothalamic Obesity, Hypothalamic Tumor
Phase 2Active not recruitingSeattle Children's Hospital242025-03-012026-10-16
Hypothalamic-Stratified Nursing Pathway for Pediatric Craniopharyngioma
Craniopharyngioma, Growth Hormone Deficiency (GHD)
CompletedWest China Hospital5002023-12-012026-01-15
Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma
Oral dabrafenib and trametinib - Craniopharyngioma
Phase 2RecruitingEva Marie Erfurth, MD, PhD252023-09-012024-02-14
FOG-001 in Locally Advanced or Metastatic Solid Tumors
FOG-001, mFOLFOX-6, Nivolumab - Cancer, Colorectal Cancer
Phase 1 / Phase 2RecruitingParabilis Medicines, Inc.6192023-05-232026-10-07
MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Binimetinib Oral Tablet [Mektovi] - Adamantinous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma
Phase 2RecruitingNationwide Children's Hospital382023-04-102026-04-08
ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Tocilizumab - Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma
Phase 2Active not recruitingNationwide Children's Hospital302022-12-162026-11-16
The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study
Saxenda - Panhypopituitarism, Craniopharyngioma
Early Phase 1UnknownSeoul National University Hospital502022-11-282024-01-23
Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
Tovorafenib - Craniopharyngioma, Child, Craniopharyngioma
Phase 2RecruitingSabine Mueller, MD, PhD572022-09-122026-04-23
Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System
tozuleristide, Canvas imaging system, Surgical resection of tumor - Central Nervous System Tumor
Phase 2CompletedJohn Yu502021-09-302026-07-10

Showing 20 of 74. Sign in to see all of them.

Narrower conditions

Meningioma (31)  ·  Astrocytoma (27)  ·  Ependymoma (27)  ·  Medulloblastoma (27)  ·  Oligodendroglioma (26)  ·  Brain Neoplasms (25)  ·  Glioma (25)  ·  Pinealoma (24)  ·  Glioblastoma (23)  ·  Choroid Plexus Neoplasms (22)  ·  Neuroectodermal Tumors, Primitive (22)  ·  Gliosarcoma (20)  ·  Glioma, Subependymal (19)  ·  Central Nervous System Neoplasms (16)

Broader conditions

Neoplasms by Histologic Type (74)  ·  Neoplasms, Nerve Tissue (74)  ·  Neuroectodermal Tumors (74)  ·  Neoplasms, Germ Cell and Embryonal (68)  ·  Neoplasms (64)  ·  Nervous System Diseases (43)  ·  Brain Diseases (40)  ·  Central Nervous System Diseases (40)  ·  Neoplasms by Site (40)  ·  Nervous System Neoplasms (39)  ·  Neoplasms, Glandular and Epithelial (35)  ·  Neoplasms, Neuroepithelial (32)  ·  Neoplasms, Vascular Tissue (31)  ·  Meningeal Neoplasms (30)  ·  Central Nervous System Neoplasms (23)

Interventions

Surgical Procedures, Operative (4)  ·  Exenatide (3)  ·  Magnetic Resonance Spectroscopy (3)  ·  2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (2)  ·  Donepezil (2)  ·  Mental Status and Dementia Tests (2)  ·  Proton Therapy (2)  ·  Radiotherapy (2)  ·  Surveys and Questionnaires (2)  ·  Temozolomide (2)  ·  tocilizumab (2)  ·  2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (1)  ·  90Y-octreotide, DOTA-Tyr(3)- (1)  ·  Amplified Fragment Length Polymorphism Analysis (1)  ·  Bevacizumab (1)

Sponsors

St. Jude Children's Research Hospital (5)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  National Institutes of Health Clinical Center (CC) (3)  ·  Wake Forest University Health Sciences (3)  ·  West China Hospital (3)  ·  Case Comprehensive Cancer Center (2)  ·  City of Hope Medical Center (2)  ·  Harry T Whelan, MD (2)  ·  Klinikum Oldenburg gGmbH (2)  ·  National Cancer Institute (NCI) (2)  ·  Nationwide Children's Hospital (2)  ·  University of Colorado, Denver (2)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  BERTHILLIER Julien (1)

Countries

United States (42)  ·  China (8)  ·  France (7)  ·  Australia (5)  ·  Germany (4)  ·  Canada (3)  ·  Netherlands (2)  ·  Belgium (1)  ·  India (1)  ·  Lebanon (1)  ·  South Korea (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Darell D. Bigner, MD, PhD (2)  ·  Harry T Whelan, MD (2)  ·  Holly Lindsay, MD (2)  ·  Jana Portnow, MD (2)  ·  Maryam Fouladi, MD (2)  ·  Shana E McCormack, MD (2)  ·  Todd C Hankinson, MD (2)  ·  A Mendez Romero (1)  ·  Antonio Omuro (1)  ·  Ashley Shoemaker, M.D. (1)  ·  Barry L Shulkin, MD (1)  ·  Benjamin Oshrine (1)  ·  Bernd Hofmann, MD (1)  ·  Blandine Gatta-Cherifi, Pr (1)

Results publications

PMID 33607632, PMID 36857103, PMID 37402092, PMID 40108339, PMID 40481916, PMID 11410496, PMID 14557435, PMID 16235676, PMID 16549835, PMID 18470481, PMID 18728566, PMID 21850464, PMID 22480131, PMID 22752346, PMID 23195688, PMID 23845268, PMID 23959584, PMID 2496905, PMID 25587648, PMID 25677941, PMID 27020837, PMID 27125511, PMID 27133664, PMID 27585663, PMID 27603903, PMID 28261955, PMID 28570730, PMID 30028528, PMID 31440945, PMID 31853886, PMID 32086697, PMID 32503055, PMID 32712149, PMID 32792133, PMID 32800304, PMID 33159114, PMID 33235996, PMID 33527610, PMID 35090129, PMID 35191944, PMID 35671519, PMID 37084748, PMID 37437144, PMID 37533236, PMID 37949931, PMID 37965466, PMID 38347552, PMID 38450721, PMID 38875730, PMID 38995891

NIH funding

P30CA033572 (2), U10CA081851 (2), P30CA008748 (1), P30CA043703 (1), P30CA086862 (1), R03CA235200 (1), R21CA218625 (1), U01CA069856 (1), U10CA180821 (1)